Lynne Kaminer

877 total citations
23 papers, 510 citations indexed

About

Lynne Kaminer is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Lynne Kaminer has authored 23 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 9 papers in Oncology and 8 papers in Immunology. Recurrent topics in Lynne Kaminer's work include Acute Myeloid Leukemia Research (8 papers), Hematopoietic Stem Cell Transplantation (8 papers) and Lymphoma Diagnosis and Treatment (7 papers). Lynne Kaminer is often cited by papers focused on Acute Myeloid Leukemia Research (8 papers), Hematopoietic Stem Cell Transplantation (8 papers) and Lymphoma Diagnosis and Treatment (7 papers). Lynne Kaminer collaborates with scholars based in United States, Philippines and Israel. Lynne Kaminer's co-authors include Montserrat Rué, Philip R. Greipp, Emily Blood, Morie A. Gertz, David H. Vesole, Stephanie Williams, Martin S. Tallman, Andrew M. Evens, Leo I. Gordon and Jane N. Winter and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Lynne Kaminer

22 papers receiving 495 citations

Peers

Countries citing papers authored by Lynne Kaminer

Since Specialization

Citations

This map shows the geographic impact of Lynne Kaminer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynne Kaminer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynne Kaminer more than expected).

Fields of papers citing papers by Lynne Kaminer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynne Kaminer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynne Kaminer. The network helps show where Lynne Kaminer may publish in the future.

Co-authorship network of co-authors of Lynne Kaminer

This figure shows the co-authorship network connecting the top 25 collaborators of Lynne Kaminer. A scholar is included among the top collaborators of Lynne Kaminer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynne Kaminer. Lynne Kaminer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A multicenter phase 1/2 trial of lenalidomide and dose-adjusted EPOCH-R in MYC-associated DLBCL 2025 ·Blood Advances ·Kirk E. Cahill, James Godfrey, Chadi Nabhan, Justin Kline, Peter A. Riedell, Kenneth S. Cohen, Sunil Narula, Theodore Karrison, (unknown), Reem Karmali, Parameswaran Venugopal, (unknown), Aaron P. Rapoport, Seung‐Tae Lee, Jennie Y. Law, Paul A. S. Fishkin, Iris Isufi, Mario R. Velasco, Lynne Kaminer, Sonali M. Smith	0
2	Tipifarnib as maintenance therapy did not improve disease-free survival in patients with acute myelogenous leukemia at high risk of relapse: Results of the phase III randomized E2902 trial 2021 ·Leukemia Research ·Selina M. Luger, (unknown), Jacob M. Rowe, Mark R. Litzow, Elisabeth Paietta, Rhett P. Ketterling, Hillard M. Lazarus, Witold B. Rybka, Michael Craig, Judith E. Karp, Brenda Cooper, Adel Makary, Lynne Kaminer, Frederick R. Appelbaum, Richard A. Larson, Martin S. Tallman	3
3	Trastuzumab-Induced Thrombocytopenia Correlated by Drug-Dependent Platelet Antibodies 2020 ·JCO Oncology Practice ·Kathleen A. Sullivan, Lynne Kaminer, David L. Grinblatt, Nicholas Campbell, (unknown), (unknown), Jason Kang, Menaka Sarav, Brian R. Curtis, Bruce Brockstein	2
4	F‐18 FDG‐PET predicts outcomes for patients receiving total lymphoid irradiation and autologous blood stem‐cell transplantation for relapsed and refractory Hodgkin lymphoma 2014 ·British Journal of Haematology ·Ryan D. Gentzler, Andrew M. Evens, Alfred Rademaker, Bing Bing Weitner, Bharat B. Mittal, Gary Dillehay, Adam M. Petrich, Jessica K. Altman, Olga Frankfurt, Daina Variakojis, Seema Singhal, Jayesh Mehta, Stephanie Williams, Lynne Kaminer, Leo I. Gordon, Jane N. Winter	29
5	Effect of an Electronic Health Record on the Culture of an Outpatient Medical Oncology Practice in a Four-Hospital Integrated Health Care System: 5-Year Experience 2011 ·Journal of Oncology Practice ·Bruce Brockstein, Thomas A. Hensing, (unknown), Jennifer Obel, Janardan D. Khandekar, Lynne Kaminer, (unknown), Robert Marsh	17
6	Optimizing the CD34 + cell dose for reduced-intensity allogeneic hematopoietic stem cell transplantation 2009 ·Leukemia & lymphoma ·Jayesh Mehta, Olga Frankfurt, Jessica K. Altman, Andrew M. Evens, Martin S. Tallman, Leo I. Gordon, Stephanie Williams, Jane N. Winter, Jairam Krishnamurthy, (unknown), (unknown), Richard Meagher, David L. Grinblatt, Lynne Kaminer, Seema Singhal	24
7	Phase I/II trial of total lymphoid irradiation and high-dose chemotherapy with autologous stem-cell transplantation for relapsed and refractory Hodgkin's lymphoma 2007 ·Annals of Oncology ·Andrew M. Evens, Jessica K. Altman, Bharat B. Mittal, Nanjiang Hou, Alfred Rademaker, David R. Patton, Lynne Kaminer, Stephanie Williams, (unknown), Daina Variakojis, Seema Singhal, Martin S. Tallman, Jayesh Mehta, Jane N. Winter, Leo I. Gordon	16
8	Daptomycin for the treatment of vancomycin resistant Enterococcus faecium bacteremia 2006 ·Scandinavian Journal of Infectious Diseases ·(unknown), (unknown), Thomas Vescio, Lynne Kaminer, Kamaljit Singh	21
9	Does younger donor age affect the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies beneficially? 2006 ·Bone Marrow Transplantation ·Jayesh Mehta, Leo I. Gordon, Martin S. Tallman, Jane N. Winter, Andrew M. Evens, Olga Frankfurt, Stephanie Williams, David L. Grinblatt, Lynne Kaminer, Richard Meagher, Seema Singhal	45
10	Submyeloablative Allogeneic HSCT for Hematologic Malignancies: Effect of Body Weight. 2006 ·Blood ·Seema Singhal, Leo I. Gordon, Martin S. Tallman, Jane N. Winter, Stephanie Williams, Olga Frankfurt, Andrew M. Evens, Richard Meagher, Lynne Kaminer, David L. Grinblatt, Jayesh Mehta	1
11	Phase II study of theophylline in chronic lymphocytic leukemia: a study of the Eastern Cooperative Oncology Group (E4998) 2004 ·Leukemia ·Peter H. Wiernik, Elisabeth Paietta, Olga Goloubeva, (unknown), Della Makower, John M. Bennett, James L. Wade, C Ghosh, Lynne Kaminer, John G. Pizzolo, Martin S. Tallman, (unknown)	20
12	The CD34+ Cell Dose, Even in an "Acceptable" Range, Affects Outcome of Allogeneic Blood Stem Cell Transplantation. 2004 ·Blood ·Seema Singhal, Leo I. Gordon, Richard Meagher, Andrew M. Evens, Martin S. Tallman, Stephanie Williams, Jane N. Winter, David L. Grinblatt, Lynne Kaminer, Jayesh Mehta	3
13	Multicenter Phase 2 Trial of Rituximab for Waldenström Macroglobulinemia (WM): An Eastern Cooperative Oncology Group Study (E3A98) 2004 ·Leukemia & lymphoma ·Morie A. Gertz, Montserrat Rué, Emily Blood, Lynne Kaminer, David H. Vesole, Philip R. Greipp	130
14	Economic analysis of a randomized placebo-controlled phase III study of granulocyte macrophage colony stimulating factor in adult patients ( > 55 to 70 years of age) with acute myelogenous leukemia 1999 ·Annals of Oncology ·Charles L. Bennett, (unknown), Martin S. Tallman, Edward A. Stadtmauer, Robert Marsh, William R. Friedenberg, H M Lazarus, Lynne Kaminer, Robert Golub, Jacob M. Rowe	46
15	Autologous Bone Marrow Transplantation Followed by Involved Field Radiotherapy in Patients with Relapsed or Refractory Hodgkin's Disease 1991 ·Leukemia & lymphoma ·Jill Moormeier, Stephanie Williams, Lynne Kaminer, Erin D. Ellis, (unknown), (unknown), Ralph R. Weichselbaum, Jacob D. Bitran	6
16	Continuous infusion mitoxantrone in relapsed acute nonlymphocytic leukemia 1990 ·Cancer ·Lynne Kaminer, Kyung Eob Choi, (unknown), Richard A. Larson	9
17	High-Dose Tri-Alkylator Chemotherapy With Autologous Stem Cell Rescue in Patients With Refractory Malignancies 1990 ·JNCI Journal of the National Cancer Institute ·Jill Moormeier, Stephanie Williams, Lynne Kaminer, (unknown), Jacob D. Bitran	23
18	Variant translocations (9;11): Identification of the critical genetic rearrangement 1988 ·Cancer Genetics and Cytogenetics ·(unknown), Elizabeth M. Davis, Michelle M. Le Beau, Mitchell A. Bitter, Lynne Kaminer, Elaine Morgan, Janet D. Rowley	12
19	A phase I-II study of bialkylator chemotherapy, high-dose thiotepa, and cyclophosphamide with autologous bone marrow reinfusion in patients with advanced cancer. 1987 ·Journal of Clinical Oncology ·Stephanie Williams, Jacob D. Bitran, Lynne Kaminer, Carol A. Westbrook, (unknown), (unknown), Erwin Robin, S Purl, (unknown), Christopher Schroeder	45
20	Molecular analysis of TCRB and ABL in a t(7;9)-containing cell line (SUP-T3) from a human T-cell leukemia. 1987 ·Proceedings of the National Academy of Sciences ·C A Westbrook, Rubin Cheng, Michelle M. Le Beau, Lynne Kaminer, SD Smith, J D Rowley, Manuel O. Dı́az	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact